Preschoolers With Cystic Fibrosis Get Close to Normal on Alyftrek
(MedPage Today) -- In cystic fibrosis, vanzacaftor-tezacaftor-deutivacaftor (VTD; Alyftrek) showed great potential for modifying the progression of disease in young children, according to the TIMBERLINE study. Assessing safety and tolerability...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.